STOCK TITAN

iRhythm Holdings (IRTC) Stock News, Apr-Aug 2023

IRTC Nasdaq

iRhythm Holdings, Inc. reports developments for a digital health care business focused on ambulatory cardiac monitoring and arrhythmia detection. The company’s recurring updates center on the Zio ambulatory ECG portfolio, which combines patch-based monitoring, AI-powered analysis, and clinical data review to deliver cardiac rhythm insights to physicians.

Company news commonly covers quarterly and annual financial results, revenue guidance, margin trends, and operating leverage, along with clinical evidence presented at cardiology meetings. Other updates include clinician education initiatives, investor conference participation, board and governance changes, and the company’s completed transition to a holding-company structure as successor registrant to iRhythm Technologies.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.26%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.26%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.81%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.2%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.12%
Tags
management
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.48%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.5%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.9%
Tags
-
Rhea-AI Summary

iRhythm Technologies (NASDAQ:IRTC) announced the release of its financial results for Q1 2023 on May 4, 2023, post-market close. The event will be followed by a live conference call at 1:30 p.m. PT/4:30 p.m. ET. Investors can access the webcast on the company’s investor relations website.

iRhythm is recognized for developing advanced digital health solutions aimed at disease detection, prevention, and prediction. Their technology integrates wearable biosensors and cloud-based analytics with proprietary algorithms to generate clinically actionable insights from cardiac data, enhancing patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.62%
Tags
conferences earnings
Rhea-AI Summary

iRhythm Technologies, Inc. (NASDAQ:IRTC) has released its 2022 Environmental, Social, and Governance (ESG) Report, highlighting its commitment to sustainable growth. President and CEO Quentin Blackford emphasized the role of ESG initiatives in supporting the company’s mission and values. Key achievements in the report include:

  • Advancing Health Equity Task Force: Established to improve access to care and address social determinants of health.
  • Diversity, Equity, Inclusion, and Belonging (DEIB): Launched new initiatives leading to 48% of employees identifying as ethnically diverse.
  • Climate Reporting: Disclosed 2022 greenhouse gas emissions and plans for further assessments.

The report outlines a strategic focus for ESG initiatives over the next three years, supported by formal board oversight.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.65%
Tags
none

FAQ

What is the current stock price of iRhythm Holdings (IRTC)?

The current stock price of iRhythm Holdings (IRTC) is $113.66 as of September 30, 2026.

What is the market cap of iRhythm Holdings (IRTC)?

The market cap of iRhythm Holdings (IRTC) is approximately 3.7B.